Fundraising FoxRecode Ventures — Full Portfolio
13 tracked investments · listed companies and verified rows first
San Francisco, US
Todd Huffman(Founder)Megan Klimen(Founder)
BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulburn(Director)inAdam Goulborn(Director)
Co-investorsComet LabsDolby Family VenturesDCVC (Data Collective)Dimension CapitalLux CapitalOS Fund
Caption Care delivers cardiac ultrasounds (echocardiograms) performed in clinics or patients' homes using AI-guided imaging and interpretation technology, enabling earlier detection of heart disease.
AI & Machine LearningDigital HealthMedical Devices
PartnerArmen A. Vidian· solo GP
Coincidence Labs builds an AI orchestration layer that connects existing systems and digitizes paper records into a unified data layer, so AI agents can execute time-sensitive tasks like regulatory documentation with human review when needed.
Advanced ManufacturingAI & Machine LearningEnterprise Software
PartnerArmen A. Vidian· solo GP
LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.
AI & Machine LearningBiotechDeep TechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Founder)in
PartnerArmen A. Vidian· solo GP
Co-investorsAcequia Capital (AceCap)Air Street CapitalAtomicoBackedBeast VenturesChampion Hill Ventures+10 more
Nanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.
BiotechHealthtechSan Francisco, US
Debesh Mandal(Founder)inChristopher Lau(Founder)inShanil Panara(Founder)in
PartnerArmen A. Vidian· solo GP
Co-investorsSterling RoadY CombinatorAgrolimen VenturesBlueYard CapitalSandhill (ex Stonks)
PartnerArmen A. Vidian· solo GP
PartnerArmen A. Vidian· solo GP
Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Lukas Lange(Founder)inHarley Katz(Founder)
PartnerArmen A. Vidian· solo GP
Co-investorsAsymmetric Capital PartnersCalm/Storm VCManta Ray VenturesOxonian VenturesThink+ Ventures Management, LlcThreshold Ventures+6 more
Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.
AI & Machine LearningHealthtechMedical DevicesSeattle, US
Gabriel Jones(Co-founder & CEO)inSamuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in
PartnerArmen A. Vidian· solo GP
Co-investorsBold Capital PartnersCota CapitalDCVC (Data Collective)Bird B. AGHTCPresence Capital+4 more
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
BoardVishal Gulati(Director)Joel Schoppig(Director)
PartnerArmen A. Vidian· solo GP
Co-investorsCivilization Ventures Management, LlcKAYATraun VenturesY CombinatorZAKA VCAmino Collective+11 more
Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.
BiotechDigital HealthHealthtechSaaS
Henning Kuich(Founder)Tomas Sabat(Founder)
BoardSunil Gupta(Strategic Advisor)
PartnerArmen A. Vidian· solo GP
Co-investorsCambridge Angels groupSuperSeed6 Dimensions CapitalManchesterStory Group, LLC
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in
PartnerArmen A. Vidian· solo GP
Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalMitsui Global InvestmentVillage Global+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Clue
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.